Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 188

1.

A peptide-modified solid lipid nanoparticle formulation of paclitaxel modulates immunity and outperforms dacarbazine in a murine melanoma model.

Banerjee I, De M, Dey G, Bharti R, Chattopadhyay S, Ali N, Chakrabarti P, Reis RL, Kundu SC, Mandal M.

Biomater Sci. 2019 Jan 17. doi: 10.1039/c8bm01403e. [Epub ahead of print]

PMID:
30652182
2.

Chinese Oak Tasar Silkworm Antheraea pernyi Silk Proteins: Current Strategies and Future Perspectives for Biomedical Applications.

Silva SS, Kundu B, Lu S, Reis RL, Kundu SC.

Macromol Biosci. 2018 Oct 8:e1800252. doi: 10.1002/mabi.201800252. [Epub ahead of print] Review.

PMID:
30294916
3.

Nerve Repair with Nerve Conduits: Problems, Solutions, and Future Directions.

Rebowe R, Rogers A, Yang X, Kundu SC, Smith TL, Li Z.

J Hand Microsurg. 2018 Aug;10(2):61-65. doi: 10.1055/s-0038-1626687. Epub 2018 Mar 20. Review.

PMID:
30154617
4.

Prospects of nonmulberry silk protein sericin-based nanofibrous matrices for wound healing - In vitro and in vivo investigations.

Sapru S, Das S, Mandal M, Ghosh AK, Kundu SC.

Acta Biomater. 2018 Sep 15;78:137-150. doi: 10.1016/j.actbio.2018.07.047. Epub 2018 Jul 29.

PMID:
30059800
5.

Optical Spectroscopic and Morphological Characterizations of Curcuminized Silk Biomaterials: A Perspective from Drug Stabilization.

Panja S, Behera S, Kundu SC, Halder M.

ACS Omega. 2017 Oct 31;2(10):6755-6767. doi: 10.1021/acsomega.7b00809. Epub 2017 Oct 16.

6.

Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer.

Kumar BNP, Puvvada N, Rajput S, Sarkar S, Mahto MK, Yallapu MM, Pathak A, Emdad L, Das SK, Reis RL, Kundu SC, Fisher PB, Mandal M.

Mol Pharm. 2018 Jul 2;15(7):2698-2713. doi: 10.1021/acs.molpharmaceut.8b00218. Epub 2018 May 30.

PMID:
29787277
7.

3D Protein-Based Bilayer Artificial Skin for the Guided Scarless Healing of Third-Degree Burn Wounds in Vivo.

Gholipourmalekabadi M, Seifalian AM, Urbanska AM, Omrani MD, Hardy JG, Madjd Z, Hashemi SM, Ghanbarian H, Brouki Milan P, Mozafari M, Reis RL, Kundu SC, Samadikuchaksaraei A.

Biomacromolecules. 2018 Jul 9;19(7):2409-2422. doi: 10.1021/acs.biomac.7b01807. Epub 2018 Apr 18.

PMID:
29529861
8.

Fabrication of Flexible, Fully Organic, Degradable Energy Storage Devices Using Silk Proteins.

Pal RK, Kundu SC, Yadavalli VK.

ACS Appl Mater Interfaces. 2018 Mar 21;10(11):9620-9628. doi: 10.1021/acsami.7b19309. Epub 2018 Mar 12.

PMID:
29480009
9.

Silk fibroin/amniotic membrane 3D bi-layered artificial skin.

Gholipourmalekabadi M, Samadikuchaksaraei A, Seifalian AM, Urbanska AM, Ghanbarian H, Hardy JG, Omrani MD, Mozafari M, Reis RL, Kundu SC.

Biomed Mater. 2018 Feb 20;13(3):035003. doi: 10.1088/1748-605X/aa999b.

PMID:
29125135
10.

Emerging tumor spheroids technologies for 3D in vitro cancer modeling.

Rodrigues T, Kundu B, Silva-Correia J, Kundu SC, Oliveira JM, Reis RL, Correlo VM.

Pharmacol Ther. 2018 Apr;184:201-211. doi: 10.1016/j.pharmthera.2017.10.018. Epub 2017 Oct 31. Review.

PMID:
29097309
11.

In Vivo Characterizations of the Immune Properties of Sericin: An Ancient Material with Emerging Value in Biomedical Applications.

Jiao Z, Song Y, Jin Y, Zhang C, Peng D, Chen Z, Chang P, Kundu SC, Wang G, Wang Z, Wang L.

Macromol Biosci. 2017 Dec;17(12). doi: 10.1002/mabi.201700229. Epub 2017 Oct 17.

PMID:
29045024
12.

Organ-on-chip models of cancer metastasis for future personalized medicine: From chip to the patient.

Caballero D, Kaushik S, Correlo VM, Oliveira JM, Reis RL, Kundu SC.

Biomaterials. 2017 Dec;149:98-115. doi: 10.1016/j.biomaterials.2017.10.005. Epub 2017 Oct 3. Review.

PMID:
29024838
13.

Silk fibroin/hydroxyapatite composites for bone tissue engineering.

Farokhi M, Mottaghitalab F, Samani S, Shokrgozar MA, Kundu SC, Reis RL, Fatahi Y, Kaplan DL.

Biotechnol Adv. 2018 Jan - Feb;36(1):68-91. doi: 10.1016/j.biotechadv.2017.10.001. Epub 2017 Oct 7. Review.

PMID:
28993220
14.

Silk scaffolds in bone tissue engineering: An overview.

Bhattacharjee P, Kundu B, Naskar D, Kim HW, Maiti TK, Bhattacharya D, Kundu SC.

Acta Biomater. 2017 Nov;63:1-17. doi: 10.1016/j.actbio.2017.09.027. Epub 2017 Sep 20. Review.

PMID:
28941652
15.

Targeted Delivery System Based on Gemcitabine-Loaded Silk Fibroin Nanoparticles for Lung Cancer Therapy.

Mottaghitalab F, Kiani M, Farokhi M, Kundu SC, Reis RL, Gholami M, Bardania H, Dinarvand R, Geramifar P, Beiki D, Atyabi F.

ACS Appl Mater Interfaces. 2017 Sep 20;9(37):31600-31611. doi: 10.1021/acsami.7b10408. Epub 2017 Sep 5.

PMID:
28836425
16.

Dual growth factor loaded nonmulberry silk fibroin/carbon nanofiber composite 3D scaffolds for in vitro and in vivo bone regeneration.

Naskar D, Ghosh AK, Mandal M, Das P, Nandi SK, Kundu SC.

Biomaterials. 2017 Aug;136:67-85. doi: 10.1016/j.biomaterials.2017.05.014. Epub 2017 May 10.

PMID:
28521202
17.

Silk fibroin-Thelebolan matrix: A promising chemopreventive scaffold for soft tissue cancer.

Mukhopadhyay SK, Naskar D, Bhattacharjee P, Mishra A, Kundu SC, Dey S.

Colloids Surf B Biointerfaces. 2017 Jul 1;155:379-389. doi: 10.1016/j.colsurfb.2017.04.011. Epub 2017 Apr 9.

PMID:
28456049
18.

Non-immunogenic, porous and antibacterial chitosan and Antheraea mylitta silk sericin hydrogels as potential dermal substitute.

Sapru S, Ghosh AK, Kundu SC.

Carbohydr Polym. 2017 Jul 1;167:196-209. doi: 10.1016/j.carbpol.2017.02.098. Epub 2017 Feb 27.

PMID:
28433154
19.

Hydroxyapatite reinforced inherent RGD containing silk fibroin composite scaffolds: Promising platform for bone tissue engineering.

Behera S, Naskar D, Sapru S, Bhattacharjee P, Dey T, Ghosh AK, Mandal M, Kundu SC.

Nanomedicine. 2017 Jul;13(5):1745-1759. doi: 10.1016/j.nano.2017.02.016. Epub 2017 Mar 8.

PMID:
28285159
20.

Gold nanoparticle-embedded silk protein-ZnO nanorod hybrids for flexible bio-photonic devices.

Gogurla N, Kundu SC, Ray SK.

Nanotechnology. 2017 Apr 7;28(14):145202. doi: 10.1088/1361-6528/aa6144. Epub 2017 Mar 9.

PMID:
28276343

Supplemental Content

Loading ...
Support Center